Cleared Traditional

K111188 - COBAS B 123 POC SYSTEM

K111188 is the FDA 510(k) clearance for COBAS B 123 POC SYSTEM by Roche Diagnostics. It is a Class 2 Chemistry device (product code CHL) cleared through the Traditional 510(k) pathway after a 383-day FDA review.

K111188 · Roche Diagnostics · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2012
Decision
383d
Days
Class 2
Risk

K111188 is an FDA 510(k) clearance for the COBAS B 123 POC SYSTEM, COBAS B 123 AUTOQC PACK TRI-LEVEL, COBAS B 123 AUTOCV.... Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on May 14, 2012 after a review of 383 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostics devices

Submission Details

510(k) Number K111188 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 27, 2011
Decision Date May 14, 2012
Days to Decision 383 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
295d slower than avg
Panel avg: 88d · This submission: 383d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 86
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K111188.
EDAN i15 Blood Gas and Chemistry Analysis System, EDAN i15 Calibrant Fluid Pack, EDAN i15 Blood Gas and Electrolyte Control, EDAN i15 Hematocrit Control
K151978 · Edan Instruments, Inc. · Jul 2016
GEM PREMIER 4000
K133407 · Instrumentation Laboratory CO · Jan 2014
MEASUREMENT OF PH IN PLEURAL FLUID ON BLOOD GAS SYSTEM
K122539 · Siemens Healthcare Diagnostics · Apr 2013
GEM PREMIER 4000 WITH IQM, MODEL 4000
K061974 · Instrumentation Laboratory CO · Sep 2006
OMNI MODULAR, OMNI C AND OMNI S ANALYZER (PH ELECTRODE)
K050423 · Roche Diagnostics · Apr 2005
STAT PROFILE PHOX PLUS L ANALYZER
K023567 · Nova Biomedical Corp. · Dec 2002